US researchers are testing YCT-529, a hormone-free male birth control pill that could redefine family planning.

YCT-529, a hormone-free male birth control pill, has shown high effectiveness in animals and is now in human trials, marking ...

The University of Minnesota College of Pharmacy ... groundwork for human clinical trials of YCT-529, which are progressing efficiently,” said Nadja Mannowetz, lead author, chief science officer and co ...

Connie Estep, Pharm.D., BCGP, director of specialty clinical solutions at Prime Therapeutics, presented on legislative impacts on site of service at this year's AMCP meeting in Houston.

A groundbreaking male birth control pill, YCT529, is being developed by researchers at the University of Minnesota in ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug ...

He holds a Bachelor of Science in Pharmacy from the University of Connecticut and is a registered pharmacist. Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment ...

To advance the profession of pharmacy, foster an environment that values employee contributions, and support development through balance and accountability. To have fun, recognize our accomplishments, ...

It is not possible to defer an offer for more than one year. Our MSc/PGDip Clinical Pharmacy course and offers a mix of clinical, applied practice, public health and research units, giving you the ...

We are thrilled to welcome Michael to Avalo’s Board of Directors during this pivotal time in our Company’s growth,” said Dr. Garry Neil, CEO of Avalo Therapeutics. “Michael’s extensive experience in ...